BLACK DIAMOND THERAPEUTICS, INC. Increase (Decrease) in Other Noncurrent Assets
BLACK DIAMOND THERAPEUTICS, INC. (BDTX) reported Increase (Decrease) in Other Noncurrent Assets of $212.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOtherNoncurrentAssets · last filed 2026-08-05
- BLACK DIAMOND THERAPEUTICS, INC. increase (decrease) in other noncurrent assets for the quarter ending 2026-06-30 was $256.00K.
- BLACK DIAMOND THERAPEUTICS, INC. increase (decrease) in other noncurrent assets for the quarter ending 2026-03-31 was -$44.00K.
- BLACK DIAMOND THERAPEUTICS, INC. increase (decrease) in other noncurrent assets for the quarter ending 2025-12-31 was -$44.00K.
- BLACK DIAMOND THERAPEUTICS, INC. increase (decrease) in other noncurrent assets for the quarter ending 2025-09-30 was -$44.00K.
- BLACK DIAMOND THERAPEUTICS, INC. increase (decrease) in other noncurrent assets for fiscal 2025 was -$176.00K, a 170.68% decline from fiscal 2024.
- BLACK DIAMOND THERAPEUTICS, INC. increase (decrease) in other noncurrent assets for fiscal 2024 was $249.00K.
- BLACK DIAMOND THERAPEUTICS, INC. increase (decrease) in other noncurrent assets for fiscal 2023 was $0.00.
- BLACK DIAMOND THERAPEUTICS, INC. increase (decrease) in other noncurrent assets for fiscal 2022 was -$16.00K.
| Period end | Increase (Decrease) in Other Noncurrent Assets 3 month | Increase (Decrease) in Other Noncurrent Assets 6 month | Increase (Decrease) in Other Noncurrent Assets 9 month | Increase (Decrease) in Other Noncurrent Assets 12 month |
|---|---|---|---|---|
| 2026-06-30 | $256.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | $212.00K 10-Q · filed 2026-08-05 | $168.00K derived: sum of 3 quarters · filed 2026-08-05 | $124.00K derived: sum of 4 quarters · filed 2026-08-05 |
| 2026-03-31 | -$44.00K 10-Q · filed 2026-05-07 | -$88.00K derived: sum of 2 quarters · filed 2026-05-07 | -$132.00K derived: sum of 3 quarters · filed 2026-05-07 | -$176.00K derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-12-31 | -$44.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-16 | -$88.00K derived: sum of 2 quarters · filed 2026-03-16 | -$132.00K derived: sum of 3 quarters · filed 2026-08-05 | -$176.00K 10-K · filed 2026-03-16 |
| 2025-09-30 | -$44.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | -$88.00K derived: sum of 2 quarters · filed 2026-08-05 | -$132.00K 10-Q · filed 2025-11-06 | -$176.00K derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-06-30 | -$44.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | -$88.00K 10-Q · filed 2026-08-05 | -$132.00K derived: sum of 3 quarters · filed 2026-08-05 | -$176.00K derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-03-31 | -$44.00K 10-Q · filed 2026-05-07 | -$88.00K derived: sum of 2 quarters · filed 2026-05-07 | -$132.00K derived: sum of 3 quarters · filed 2026-05-07 | $205.00K derived: sum of 4 quarters · filed 2026-05-07 |
| 2024-12-31 | -$44.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-16 | -$88.00K derived: sum of 2 quarters · filed 2026-03-16 | $249.00K derived: sum of 3 quarters · filed 2026-03-16 | $249.00K 10-K · filed 2026-03-16 |
| 2024-09-30 | -$44.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | $293.00K derived: sum of 2 quarters · filed 2025-11-06 | $293.00K 10-Q · filed 2025-11-06 | $293.00K derived: sum of 4 quarters · filed 2025-11-06 |
| 2024-06-30 | $337.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07 | $337.00K 10-Q · filed 2025-08-07 | $337.00K derived: sum of 3 quarters · filed 2025-08-07 | $337.00K derived: sum of 4 quarters · filed 2025-08-07 |
| 2024-03-31 | $0.00 10-Q · filed 2025-05-12 | $0.00 derived: sum of 2 quarters · filed 2025-05-12 | $0.00 derived: sum of 3 quarters · filed 2025-05-12 | $0.00 derived: sum of 4 quarters · filed 2025-05-12 |
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-06 | $0.00 derived: sum of 2 quarters · filed 2025-03-06 | $0.00 derived: sum of 3 quarters · filed 2025-03-06 | $0.00 10-K · filed 2025-03-06 |
| 2023-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-05 | $0.00 derived: sum of 2 quarters · filed 2024-11-05 | $0.00 10-Q · filed 2024-11-05 | $0.00 derived: sum of 4 quarters · filed 2024-11-05 |
| 2023-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-06 | $0.00 10-Q · filed 2024-08-06 | $0.00 derived: sum of 3 quarters · filed 2024-08-06 | -$10.00K derived: sum of 4 quarters · filed 2024-08-06 |
| 2023-03-31 | $0.00 10-Q · filed 2023-05-09 | $0.00 derived: sum of 2 quarters · filed 2024-03-12 | -$10.00K derived: sum of 3 quarters · filed 2024-03-12 | -$10.00K derived: sum of 4 quarters · filed 2024-03-12 |
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-12 | -$10.00K derived: sum of 2 quarters · filed 2024-03-12 | -$10.00K derived: sum of 3 quarters · filed 2024-03-12 | -$16.00K 10-K · filed 2024-03-12 |
| 2022-09-30 | -$10.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-06 | -$10.00K derived: sum of 2 quarters · filed 2023-11-06 | -$16.00K 10-Q · filed 2023-11-06 | -$99.00K derived: sum of 4 quarters · filed 2023-11-06 |
| 2022-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-11 | -$6.00K 10-Q · filed 2023-08-11 | -$89.00K derived: sum of 3 quarters · filed 2023-08-11 | -$88.00K derived: sum of 4 quarters · filed 2023-08-11 |
| 2022-03-31 | -$6.00K 10-Q · filed 2023-05-09 | -$89.00K derived: sum of 2 quarters · filed 2023-05-09 | -$88.00K derived: sum of 3 quarters · filed 2023-05-09 | -$90.00K derived: sum of 4 quarters · filed 2023-05-09 |
| 2021-12-31 | -$83.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-09 | -$82.00K derived: sum of 2 quarters · filed 2023-03-09 | -$84.00K derived: sum of 3 quarters · filed 2023-03-09 | -$90.00K 10-K · filed 2023-03-09 |
| 2021-09-30 | $1.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-08 | -$1.00K derived: sum of 2 quarters · filed 2022-11-08 | -$7.00K 10-Q · filed 2022-11-08 | $7.00K derived: sum of 4 quarters · filed 2022-11-08 |
| 2021-06-30 | -$2.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-09 | -$8.00K 10-Q · filed 2022-08-09 | $6.00K derived: sum of 3 quarters · filed 2022-08-09 | $18.00K derived: sum of 4 quarters · filed 2022-08-09 |
| 2021-03-31 | -$6.00K 10-Q · filed 2022-05-11 | $8.00K derived: sum of 2 quarters · filed 2022-05-11 | $20.00K derived: sum of 3 quarters · filed 2022-05-11 | $21.00K derived: sum of 4 quarters · filed 2022-05-11 |
| 2020-12-31 | $14.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-17 | $26.00K derived: sum of 2 quarters · filed 2022-03-17 | $27.00K derived: sum of 3 quarters · filed 2022-03-17 | $47.00K 10-K · filed 2022-03-17 |
| 2020-09-30 | $12.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-08 | $13.00K derived: sum of 2 quarters · filed 2021-11-08 | $33.00K 10-Q · filed 2021-11-08 | $59.00K derived: sum of 4 quarters · filed 2021-11-08 |
| 2020-06-30 | $1.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-12 | $21.00K 10-Q · filed 2021-08-12 | $47.00K derived: sum of 3 quarters · filed 2021-08-12 | $57.00K derived: sum of 4 quarters · filed 2021-08-12 |
| 2020-03-31 | $20.00K 10-Q · filed 2021-05-07 | $46.00K derived: sum of 2 quarters · filed 2021-05-07 | $56.00K derived: sum of 3 quarters · filed 2021-05-07 | $55.00K derived: sum of 4 quarters · filed 2021-05-07 |
| 2019-12-31 | $26.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-25 | $36.00K derived: sum of 2 quarters · filed 2021-03-25 | $35.00K derived: sum of 3 quarters · filed 2021-03-25 | $51.00K 10-K · filed 2021-03-25 |
| 2019-09-30 | $10.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-10 | $9.00K derived: sum of 2 quarters · filed 2020-11-10 | $25.00K 10-Q · filed 2020-11-10 | |
| 2019-06-30 | -$1.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-11 | $15.00K 10-Q · filed 2020-08-11 | ||
| 2019-03-31 | $16.00K 10-Q · filed 2020-05-12 | |||
| 2018-12-31 | $3.00K 10-K · filed 2020-03-24 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cardiff Oncology, Inc. (CRDF) | United States | $0.101B | -2.22 |
| LENZ Therapeutics, Inc. (LENZ) | United States | $0.117B | -1.41 |
| COGNITION THERAPEUTICS INC (CGTX) | United States | $0.090B | -6.52 |
| enGene Therapeutics Inc. (ENGN) | $0.129B | -0.92 | |
| Pelthos Therapeutics Inc. (PTHS) | United States | $0.086B | -1.20 |
| Atara Biotherapeutics, Inc. (ATRA) | United States | $0.086B | -6.48 |
| Neumora Therapeutics, Inc. (NMRA) | United States | $0.132B | -1.48 |
| Armata Pharmaceuticals, Inc. (ARMP) | United States | $0.132B | |
| Caribou Biosciences, Inc. (CRBU) | United States | $0.134B | -1.79 |
| Vaxart, Inc. (VXRT) | United States | $0.080B | 3.84 |